Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
9.46
-0.33 (-3.37%)
At close: Oct 22, 2026, 4:00 PM EDT
9.40
-0.06 (-0.63%)
After-hours: Oct 22, 2026, 7:30 PM EDT
Gossamer Bio Market Cap
Gossamer Bio has a market cap or net worth of $57.86 million as of October 22, 2026. It is the 29,034th most valuable company in the world and the 4,504th biggest in the United States. Its market cap has decreased by 88.45% in one year.
Market Cap
57.86M
Enterprise Value
40.90M
1-Year Change
-88.45%
Global Rank
Country Rank
#4,504 United States
Category
ChartMarket Cap Chart
Since February 8, 2019, Gossamer Bio's market cap has decreased from $995.26M to $57.86M, a decrease of -94.19%. That is a compound annual growth rate of -30.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 57.86M | -91.94% |
| Dec 31, 2025 | 717.51M | 250.03% |
| Dec 31, 2024 | 204.99M | -0.34% |
| Dec 29, 2023 | 205.69M | 0.56% |
| Dec 30, 2022 | 204.54M | -76.06% |
| Dec 31, 2021 | 854.34M | 21.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xilio Therapeutics | 54.81M |
| Gain Therapeutics | 54.55M |
| Boundless Bio | 52.54M |
| RenovoRx | 52.35M |
| Alterity Therapeutics | 51.20M |
| Werewolf Therapeutics | 50.54M |
| Eloxx Pharmaceuticals | 50.46M |
| Caribou Biosciences | 49.74M |